Press Releases

  • Test predicts lymphoma therapy success

    Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.


  • Anesthesiologist Kevin Malott dies

    Malott, who was honored as the favorite instructor of Stanford’s anesthesiology residents in 2014, enjoyed providing care for young children.


  • Cell death via trigger waves

    In a cell, death is akin to falling dominoes: One death-inducing molecule activates another, and so on, until the entire cell is shut down, a new Stanford study finds.


  • Common skin cancer linked to other cancers

    Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.


  • Brain circuit tied to sociability

    Autism spectrum disorder is marked by severe social deficits. Stanford researchers were able to reverse those types of deficits in mice by activating a single brain circuit.


  • Device helps kids with autism read looks

    Wearing a device that identifies other people’s facial expressions can help children with autism develop better social skills, a Stanford pilot study has demonstrated.


  • Depression, blood levels of substance linked

    Investigators at Stanford and elsewhere have shown, for the first time in humans, that low blood levels of acetyl-L-carnitine track with the severity and duration of depression.


  • Genetic screen predicts osteoporosis risk

    A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.


  • Gut molecule protects against Salmonella

    A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.


  • Lay worker effective in end-of-life talks

    The findings suggest that patients with a serious illness are more at ease with decisions about their care when they discuss their care preferences with someone outside the medical context, according to Stanford researchers.



Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.